-
CF: Orkambi Reimbursement Approved in France for Patients 2 or Older
French authorities have approved national reimbursement of Orkambi for cystic fibrosis patients 2 or older, with two copies of the F508del mutation. Click here to read more about it.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.